Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain forms of triple-negative breast cancer (TNBC). It is approved for adults with high-risk early-stage TNBC in…
Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with triple-negative breast cancer (TNBC). Keytruda is indicated to treat early-stage, high-risk TNBC… read more